




Searching News Database: irritable bowel syndrome
HSMN NewsFeed - 4 Apr 2022
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
HSMN NewsFeed - 24 Oct 2018
Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device
Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device
HSMN NewsFeed - 25 Apr 2018
FDA Grants Fast Track Designation for OrphoMed's ORP-101 for Treatment of IBS-D
FDA Grants Fast Track Designation for OrphoMed's ORP-101 for Treatment of IBS-D
HSMN NewsFeed - 7 Mar 2018
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
HSMN NewsFeed - 5 Mar 2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
HSMN NewsFeed - 3 Jan 2018
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
HSMN NewsFeed - 12 Sep 2017
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
HSMN NewsFeed - 12 May 2017
Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C
Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C
HSMN NewsFeed - 28 Mar 2017
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
HSMN NewsFeed - 11 May 2016
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
HSMN NewsFeed - 9 May 2016
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
HSMN NewsFeed - 29 Feb 2016
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
HSMN NewsFeed - 8 Jul 2015
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer
HSMN NewsFeed - 3 Sep 2014
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
HSMN NewsFeed - 13 Mar 2014
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
HSMN NewsFeed - 18 Jun 2013
John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations
John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations
HSMN NewsFeed - 17 Dec 2012
Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA
Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA
HSMN NewsFeed - 24 Mar 2011
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
HSMN NewsFeed - 22 Mar 2011
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
HSMN NewsFeed - 17 Feb 2010
Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome
Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome
HSMN NewsFeed - 17 Feb 2009
Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
HSMN NewsFeed - 7 Aug 2008
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
HSMN NewsFeed - 3 Jun 2008
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
HSMN NewsFeed - 6 Feb 2008
Apex Bioventures and Dynogen Pharmaceuticals Announce Definitive Merger Agreement
Apex Bioventures and Dynogen Pharmaceuticals Announce Definitive Merger Agreement
HSMN NewsFeed - 14 Jan 2008
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 18 Dec 2007
Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
HSMN NewsFeed - 3 Oct 2007
Callisto Pharmaceuticals Announces Major Strategic Initiative for Guanilib in GI Disorders
Callisto Pharmaceuticals Announces Major Strategic Initiative for Guanilib in GI Disorders
HSMN NewsFeed - 17 Sep 2007
Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
HSMN NewsFeed - 12 Jun 2007
Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
HSMN NewsFeed - 26 Apr 2007
Lexicon Genetics Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses
Lexicon Genetics Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses
HSMN NewsFeed - 30 Mar 2007
Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request from FDA
Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request from FDA
HSMN NewsFeed - 21 Mar 2007
Lexicon Genetics Appoints Tamar Howson Executive Vice President of Business Development
Lexicon Genetics Appoints Tamar Howson Executive Vice President of Business Development
HSMN NewsFeed - 14 Mar 2007
Napo Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment
Napo Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment
HSMN NewsFeed - 20 Feb 2007
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
HSMN NewsFeed - 22 Jan 2007
Neurocrine Announces Plans to Resubmit NDA for Indiplon Capsules in Q2 2007
Neurocrine Announces Plans to Resubmit NDA for Indiplon Capsules in Q2 2007
HSMN NewsFeed - 19 Jan 2007
Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor for Capsaicin-induced Pain
Pharmos Announces Clinical Data from Phase 2a Trial of Cannabinor for Capsaicin-induced Pain
HSMN NewsFeed - 5 Dec 2006
Lexicon Genetics Files Investigational New Drug Application for LX1031 in Irritable Bowel Syndrome
Lexicon Genetics Files Investigational New Drug Application for LX1031 in Irritable Bowel Syndrome
HSMN NewsFeed - 23 Oct 2006
New Data for Zelnorm(R) Demonstrate Relief of Multiple Symptoms of Dysmotility-Type Dyspepsia
New Data for Zelnorm(R) Demonstrate Relief of Multiple Symptoms of Dysmotility-Type Dyspepsia
HSMN NewsFeed - 14 Sep 2006
BioBalance Announces the Resignation of Its CEO and the Assumption of Additional Duties by Richard Serbin
BioBalance Announces the Resignation of Its CEO and the Assumption of Additional Duties by Richard Serbin
HSMN NewsFeed - 10 May 2006
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
Additional items found! 138

Members Archive contains
138 additional stories matching:
irritable bowel syndrome
(Password required)
irritable bowel syndrome
(Password required)